Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 has been removed.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision tag updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.4.2 and removed an outdated funding-status notice and an earlier revision note, representing site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedAdded a government-funding lapse notice and updated the page revision to v3.4.1; removed the previous revision v3.4.0.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check76 days agoChange DetectedThis page update shows a system revision from v3.3.3 to v3.3.4 and does not modify study details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.